Biopolym. Cell. 2021; 37(3):177-184.
http://dx.doi.org/10.7124/bc.000A55
Bioorganic Chemistry
Identification of novel protein kinase CK2 inhibitors among indazole derivatives
1Vdovin V. S., 1Lukashov S. S., 1Borysenko I. P., 1Borovykov O. V., 1Protopopov M. V., 1Bdzhola V. G., 1Yarmoluk S. M.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03143

Abstract

Aim. To synthesize the novel purine bioisosteres – indazole derivatives and evaluate inhibitory activity of these compounds towards CK2 in the in vitro system. Methods. Chemical synthesis, 1H and 13C NMR spectroscopy, LC-MS method, determination of residual enzyme activity using ATP consumption tests with a luciferase Kinase-Glo® luminescent kinase assay. Results. Known synthetic methods of indazole chemistry were originally applied to the synthesis of 3-aryl-indazole-7-carboxylic acids. Conditions of cross-coupling of 3-bromo-indazole derivatives with arylboronic acids were substantially improved. 3-aryl-indazole 5- and 7-carboxylic acids have shown IC50 in a range 3.1–6.5 μM in luciferase luminescent kinase assay. Conclusions. The synthesis of 3-aryl-indazole-7-carboxylic acids has been developed. Novel inhibitors of the protein kinase CK2 among indazole derivatives have been identified among the 3-aryl-indazole 5- and 7-carboxylic acids. It has been shown the crucial impact of carboxyl group on the inhibitory activity of studied compounds.
Keywords: Indazole, chemical synthesis, luciferase luminescent kinase assay, protein kinase inhibitor, protein kinase CK2
Full text: (PDF, in English)

References

[1] Bian Y, Ye M, Wang C, Cheng K, Song C, Dong M, Pan Y, Qin H, Zou H. Global screening of CK2 kinase sub-strates by an integrated phosphoproteomics workflow. Sci Rep. 2013; 3(3460):1-7.
[2] Ahmad KA, Wang G, Unger G, Slaton J, Ahmed K. Protein kinase CK2 - a key suppressor of apoptosis. Ad-vances in Enzyme Regulation. 2008; 48:179-87.
[3] Ruzzene M, Pinna LA. Addiction to protein kinase CK2: a common denominator of diverse cancer cells? Biochim Biophys Acta. 2010; 1804(3):499-504.
[4] Christian Borgo and Maria Ruzzene Role of protein kinase CK2 in antitumor drug resistance. J Exp Clin Cancer Res. 2019; 38:287.
[5] Wilson LK, Dhillon N, Thorner J, Martin GS. Casein kinase II catalyzes tyrosine phosphorylation of the yeast nucleolar immunophilin Fpr3. J Biol Chem. 1997; 272(20):12961-12967.
[6] Faust M, Montenarh M. Subcellular localization of protein kinase CK2: A key to its function? Cell Tissue Res. 2000; 301(3):329-340.
[7] Sarno S, Pinna LA. Protein kinase CK2 as a druggable target. Mol Biosyst. 2008; 4(9):889-894.
[8] Sarno S, Reddy H, Meggio F, Ruzzene M, Davies SP, Donella-Deana A, Shugar D, Pinna LA. Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2'). FEBS Lett. 2001; 496(1):44-48.
[9] Battistutta R, De Moliner E, Sarno S, Zanotti G, Pinna LA. Structural features underlying selective inhibition of protein kinase CK2 by ATP site-direc-ted tetrabromo-2-benzotriazole. Protein Sci. 2001; 10(11):2200-2206.
[10] Szyszka R, Grankowski N, Felczak K, Shugar D. Halogenated benzimidazoles and benzotriazoles as selective inhibitors of protein kinases CK I and CK II from Saccharomyces cerevisiae and other sour-ces. Biochim Biophys Res Commun. 1995; 208(1):418-424.
[11] Pagano M, Andrzejewska M, Ruzzene M, Sarno S, Cesaro L, Bain J, Elliott M, Meggio F, Kazimierczuk Z, Pinna LA. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole. J Med Chem. 2004; 47(25):6239-6247.
[12] Wąsik R, Wińska P, Poznański J, Shugar D. Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α. PLoS One. 2012; 7(11):e48898.
[13] Gianoncelli A, Cozza G, Orzeszko A, Meggio F, Kazimierczuk Z, Pinna LA. Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2. Bioorg Med Chem. 2009; 17(20):7281-7289.
[14] Meggio F, Shugar D, Pinna L. Ribofuranosyl-benzimidazole derivatives as inhibitors of casein kinase-2 and casein kinase-1. Eur J Biochem. 1990; 187(1):89-94.
[15] Yim H, Lee Y, Lee S. Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor. Planta Med. 1999; 65(1):9-13.